XML 32 R52.htm IDEA: XBRL DOCUMENT v3.20.1
Segments of Business and Geographic Areas - Operating Profit by Segment of Business (Details) - USD ($)
$ in Millions
3 Months Ended
Mar. 29, 2020
Mar. 31, 2019
Segment Reporting Information [Line Items]    
Percentage Change In Sales By Geographic Area 3.30%  
Sales to customers $ 20,691 $ 20,021
Percentage Change in Operating Income Loss 47.20%  
Earnings before provision for taxes on income $ 6,509 4,422
In-process research and development 0 890
Reversal of contingent consideration 983 0
Restructuring charges 58 36
Consumer Health    
Segment Reporting Information [Line Items]    
Sales to customers 3,625 3,318
PHARMACEUTICAL    
Segment Reporting Information [Line Items]    
Sales to customers 11,134 10,244
In-process research and development   900
Litigation expense 100 300
Research and Development Expense   300
Medical Devices    
Segment Reporting Information [Line Items]    
Sales to customers 5,932 6,459
Restructuring charges 100 100
Litigation expense 100  
Operating Segments    
Segment Reporting Information [Line Items]    
Total Segment Operating Income $ 6,629 4,569
Percentage Change in Operating Income Loss 45.10%  
Operating Segments | Consumer Health    
Segment Reporting Information [Line Items]    
Total Segment Operating Income $ 770 741
Percentage Change in Operating Income Loss 3.90%  
Amortization $ 100 100
Operating Segments | PHARMACEUTICAL    
Segment Reporting Information [Line Items]    
Total Segment Operating Income $ 3,834 2,331
Percentage Change in Operating Income Loss 64.50%  
Amortization $ 800 800
Unrealized Gain (Loss) on Securities 300 100
Operating Segments | Medical Devices    
Segment Reporting Information [Line Items]    
Total Segment Operating Income $ 2,025 1,497
Percentage Change in Operating Income Loss 35.30%  
Amortization $ 200 200
Corporate, Non-Segment    
Segment Reporting Information [Line Items]    
Total Segment Operating Income 120 147
Ci:z Holdings Co. Ltd. | Consumer Health    
Segment Reporting Information [Line Items]    
Gain on sale of equity investments   300
Auris Health    
Segment Reporting Information [Line Items]    
Reversal of contingent consideration $ 983  
United States    
Segment Reporting Information [Line Items]    
Percentage Change In Sales By Geographic Area 5.60%  
Sales to customers $ 10,699 10,129
United States | Consumer Health    
Segment Reporting Information [Line Items]    
Sales to customers 1,740 1,438
United States | PHARMACEUTICAL    
Segment Reporting Information [Line Items]    
Sales to customers 6,061 5,582
United States | Medical Devices    
Segment Reporting Information [Line Items]    
Sales to customers $ 2,898 3,109
Europe    
Segment Reporting Information [Line Items]    
Percentage Change In Sales By Geographic Area 4.70%  
Sales to customers $ 4,827 4,609
Western Hemisphere, excluding U.S.    
Segment Reporting Information [Line Items]    
Percentage Change In Sales By Geographic Area (0.10%)  
Sales to customers $ 1,502 1,503
Asia-Pacific, Africa    
Segment Reporting Information [Line Items]    
Percentage Change In Sales By Geographic Area (3.10%)  
Sales to customers $ 3,663 $ 3,780
Other Income | Auris Health    
Segment Reporting Information [Line Items]    
Reversal of contingent consideration $ 1,000